Literature DB >> 17548688

Prospective cohort study of green tea consumption and colorectal cancer risk in women.

Gong Yang1, Xiao-Ou Shu, Honglan Li, Wong-Ho Chow, Bu-Tian Ji, Xianglan Zhang, Yu-Tang Gao, Wei Zheng.   

Abstract

Tea and its constituents have shown anticarcinogenic activities in in vitro and animal studies. Epidemiologic studies, however, have been inconsistent. We prospectively evaluated the association between green tea consumption and colorectal cancer (CRC) risk in a cohort of 69,710 Chinese women aged 40 to 70 years. Information on tea consumption was assessed through in-person interviews at baseline and reassessed 2 to 3 years later in a follow-up survey. During 6 years of follow-up, 256 incident cases of CRC were identified. The multivariate relative risk of CRC was 0.63 (95% confidence interval, 0.45-0.88) for women who reported drinking green tea regularly at baseline compared with nonregular tea drinkers. A significant dose-response relationship was found for both the amount of tea consumed (Ptrend = 0.01) and duration in years of lifetime tea consumption (Ptrend = 0.006). The reduction in risk was most evident among those who consistently reported to drink tea regularly at both the baseline and follow-up surveys (relative risk, 0.43; 95% confidence interval, 0.24-0.77). The inverse association with regular tea drinking was observed for both colon and rectal cancers. This study suggests that regular consumption of green tea may reduce CRC risk in women.

Entities:  

Mesh:

Year:  2007        PMID: 17548688     DOI: 10.1158/1055-9965.EPI-07-0097

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  37 in total

1.  Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies.

Authors:  Xuehong Zhang; Demetrius Albanes; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Andrew Flood; Jo L Freudenheim; Edward L Giovannucci; R Alexandra Goldbohm; Karen Jaceldo-Siegl; Eric J Jacobs; Vittorio Krogh; Susanna C Larsson; James R Marshall; Marjorie L McCullough; Anthony B Miller; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Sabina Sieri; Donna Spiegelman; Jarmo Virtamo; Alicja Wolk; Walter C Willett; Shumin M Zhang; Stephanie A Smith-Warner
Journal:  J Natl Cancer Inst       Date:  2010-05-07       Impact factor: 13.506

2.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

Review 3.  Tea and health: preventive and therapeutic usefulness in the elderly?

Authors:  Bradley W Bolling; Chung-Yen Oliver Chen; Jeffrey B Blumberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

Review 4.  Diet, the gut microbiome, and epigenetics.

Authors:  Meredith A J Hullar; Benjamin C Fu
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 5.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

6.  Cancer prevention by green tea: evidence from epidemiologic studies.

Authors:  Jian-Min Yuan
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

Review 7.  Flavonoids and age-related disease: risk, benefits and critical windows.

Authors:  J K Prasain; S H Carlson; J M Wyss
Journal:  Maturitas       Date:  2010-02-23       Impact factor: 4.342

Review 8.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

9.  Recent advances in colorectal cancer research: the microenvironment impact.

Authors:  Anne-Laure Pin; François Houle; Jacques Huot
Journal:  Cancer Microenviron       Date:  2011-08

10.  Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.

Authors:  Vondina R Moseley; Jay Morris; Rebecca W Knackstedt; Michael J Wargovich
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.